Unfold AI is designed to help physicians identify cancerous tissue. Source: Avenda Health
Prostate treatment has improved with robotics, and it could improve again soon with artificial intelligence. Avenda Health today announced Surgery Mode, a new suit of interoperative features for its Unfold AI offering. The multimodal AI-powered prostate cancer mapping platform is designed to reveal the true size and extent of disease to help physicians make better informed treatment decisions.
“Our goal with Unfold AI has always been to provide more clinical clarity throughout every stage of a patient’s cancer journey,” stated Shyam Natarajan, Ph.D., co-founder and CEO of Avenda Health.
“Whether a physician is counseling a newly diagnosed patient, planning a targeted radiation oncology treatment, or performing a complex radical prostatectomy, having an accurate 3D map of the disease is transformative,” he added. “These new surgical enhancements empower physicians with the visual confidence needed to achieve optimal cancer control while protecting patient quality of life during complex procedures.”
Founded in 2017, Avenda Health said it is creating a more personalized future of prostate cancer care. With deep learning, the Culver City, Calif.-based company‘s software maps a patient’s cancer in 3D, giving physicians precise information and the confidence to make care decisions. Avenda said it aims to improve outcomes, preserve quality of life, and create a new standard of prostate cancer care.
Avenda Health said it designed Surgery Mode to enhance how surgeons use 3D AI mapping during non-robotic and robotic surgeries , alongside new tools to simplify patient case management and physician workflows.
Source link







